Abu Dhabi becomes first city to get revolutionary anti-viral medicine for Covid


Daijiworld Media Network - Abu Dhabi (SP)

Abu Dhabi, Jun 16: As per an agreement reached between Abu Dhabi health department and GlaxoSmithKline, the city became the first in the world to receive antiviral treatment drug for Covid-19, Sotrovimab. The first ever consignment of this revolutionary drug was received by the city on Wednesday June 15.

Sotrovimab is a monoclonal antibody treatment delivered through intravenous therapy for adults and children above 12 years of age who are at risk for progressing to severe Covid-19. Clinical trials have shown that the drug prevents hospitalisation and death in 85 percent of cases and the drug works on all variants of the virus till now.

The UAE health ministry gave its approval for the drug after USA Food and Drug Administration allowed emergency use of this medicine. Under secretary in the department of health, UAE, Dr Jama Mohammed Kaabi, said that Abu Dhabi continues with its efforts to maintain its number one city position globally in terms of safety in Covid-19 times. Rashd Al Qubaisi, CEO of Abu-Dhabi based Rafed, which facilitates the procurement of the medicine, said that Sotrovimab is a huge breakthrough in the fight against Covid-19.The health department is working out the eligibility for Sotrovimab treatment.

 

 

 

 

 

  

Top Stories

Comment on this article

  • Dev, Mangalore

    Fri, Jun 18 2021

    Good to know about alternative treatments from Rudolf & Dr Monty . One treatment which is working now 100% of the time is Dr Biswaroop's Flu Diet which is a naturopathic support of our immune system without interfering with its functions by not administering any medicines which stop it from performing. Good to see now MLA s are cooperating with his NICE team in establishing open air camps where patients are treated with love and discarding fear causing PPE kits, masks or sanitizers , all comorbid and serious patients too are getting well without any oxygen and ventilators, all cases are well documented with all parameters recorded with test reports from reputed labs. Thanks for their efforts despite facing many hurdles and no help from Health Minister Harshwardhan since last March 5th of 2020, Maharashtra, Rajasthan are leading to spread the awareness. Time for people who tried to stop him helping the diseased by labelling him as quack or fake to apologise and free our nation from outward tyranny by a few greedy people through their puppets like WHO and ICMR as well as paid media.

    DisAgree [1] Agree [3] Reply Report Abuse

  • Alex, Mangalore

    Fri, Jun 18 2021

    Why dont they try " Ivermectin" appox 15mg per day. There is proof it is 80% very effective, even to reduce risk of catching Covid. Because Ivermectin is very cheap, pharma cannot make lot money perhaps.

    DisAgree [1] Agree [5] Reply Report Abuse

  • Monty Dotor, Mangalore

    Fri, Jun 18 2021

    @Alex Many antiparasitic drugs like ivermectin, pyrimethamine and chloroquine may work as a prophylactic ( preventive) or if given in a very early stage as a viral suppressant to reduce the morbidity of Covid. The side effects are exaggerated and results in trials twisted because they are cheap.All are known to suppress viral replication.

    DisAgree Agree [6] Reply Report Abuse

  • Rudolf Rodrigues, Mumbai

    Thu, Jun 17 2021

    Dear Monty, Even MABS are proving to be a failure, read: " London, Jun 16 (IANS): British-Swedish biopharmaceutical company AstraZeneca on Tuesday stated that its monoclonal antibody treatment failed to prevent the Covid-19 symptoms in individuals already exposed to the virus. "The Covid-19 antibody therapy -- AZD7442 -- was only 33 percent effective in reducing the risk of symptoms, when compared to a placebo, according to the results of a Phase 3 trial. "While this trial did not meet the primary endpoint against symptomatic illness, we are encouraged by the protection seen in the PCR negative participants following treatment with AZD7442," Executive Vice President, BioPharmaceuticals R&D, Mene Pangalos, said in a statement.The Phase 3 trial included 1,121 participants, from the UK and the US. The participants were unvaccinated adults 18 years and above with confirmed exposure to a person with a case of the SARS-CoV-2 virus within the past eight days. All participants had a negative SARS-CoV-2 antibody test on the day of dosing to exclude prior infection, and a nasopharyngeal swab was also collected and subsequently analysed for SARS-CoV-2 by RT-PCR to detect virus. The results are not peer-reviewed yet. The results of the study suggest that AZD7442 may be useful in preventing symptomatic Covid-19 in individuals not already infected," said principal investigator on the trial Myron J Levin, Professor at University of Colorado School of Medicine, US. AZD7442 is a combination of two LAABs - tixagevimab (AZD8895) and cilgavimab (AZD1061) - derived from B cells donated by convalescent patients after SARS-CoV-2 virus. Discovered by Vanderbilt University Medical Center and licensed to AstraZeneca in June 2020, the human monoclonal antibodies bind to distinct sites on the SARS-CoV-2 spike protein2 and were optimised by AstraZeneca with half-life extension and reduced Fc receptor binding. The therapy is currently being tested in several additional Covid prevention and..

    DisAgree [1] Agree [4] Reply Report Abuse

  • Monty Dotor, Mangalore

    Thu, Jun 17 2021

    Thanks for the info

    DisAgree [1] Agree [3] Reply Report Abuse

  • Monty Dotor, Mangalore

    Thu, Jun 17 2021

    @Ajay I had written and telephonically talked to the owners/ CEO of 3 large Indian pharma companies,who were my patients about manufacturing Corona specific Human Normal Immunoglobulin/ antibodies - which would have cost Rs 25 per shot compared to a higher price for monoclonal antibodies.( I had written to our PM also, ) way back on 17 Feb 2020. The pharma companies told me that it is not financially prudent for them to manufacturer cheaper things when they can market something costlier. I had written to 4 world leaders also about immunoglobulin and "mabs" - A US company Regeneron produced "Mab" and past president Trump was given it when he had covid.Israel company Kamada pharma produced and marketed it. They say that it is effective but the way pharma trials are manipulated here and abroad, it is difficult to know where we stand.

    DisAgree [1] Agree [15] Reply Report Abuse

  • Alex, Mangalore

    Fri, Jun 18 2021

    This is all the drama for making money at the cost of other's lives. There is ulterior motives behind it. Cheapest drug " Ivermectin" is also suppressed.

    DisAgree Agree [1] Reply Report Abuse

  • sense_Shetty, MAngalore

    Thu, Jun 17 2021

    This is ponds powder in action ..This is how they built oasis in desert which after all is a mirage.. In India the opposition parties would have brought down the sachets themselves.

    DisAgree [6] Agree [1] Reply Report Abuse

  • Dev, Mangalore

    Thu, Jun 17 2021

    Mad rush by many countries as soon as any new drugs or treatment for corona makes news. As per well-known Daiji friend Monty Doc it is effective. Whether effective or not it doesn't matter as long as it doesn't hurt recipients with adverse vaccine injuries or deaths. According to one doctor the DRDO invention is nothing new and it had been shelved by some countries as not effective way back since many years. UAE has stealthily vaccinated its population by asking the companies to force their employees to have unproven experimental vaccines, if anything happens to police, doctors and nurses with prominent leaders in some fictional scenario ñot even God can help the nations as they have brought it upon themselves by believing unsettled science and scientists who have created the present planndemic.

    DisAgree [8] Agree [4] Reply Report Abuse

  • Monty Dotor, Mangalore

    Thu, Jun 17 2021

    @Dev BTW I am not a well known doctor and practically few know me in Mangalore as I prefer to be very low profile., I am not an expert either, I prefer to be a learner till my last breath.2DG of DRDO is 2 deoxy D glucose where the 2 hydroxy group in glucose is replaced by H.It acts by competitive inhibition of glucose 6phosphate.It is used as an experimental drug in cancers and covid.Indian and foreign trials differ in the efficacy reports.Long term side effects are not known.The price is around Rs 900 per sachet.

    DisAgree [7] Agree [9] Reply Report Abuse

  • Ajay Rebello, Kallianpur

    Thu, Jun 17 2021

    Sir thank you for your enlightened comment. God knows why India is not mass producing this.

    DisAgree [1] Agree [8] Reply Report Abuse

  • SJM, Mangalore

    Thu, Jun 17 2021

    Great News for UAE nationals & residents. Hope it will come other countries soon. In India DRDO's Anti-Covid Drug 2-DG Found Effective against All Covid-19 Variants but implementation sounds low with big voice.

    DisAgree [3] Agree [22] Reply Report Abuse

  • Monty Dotor, Mangalore

    Thu, Jun 17 2021

    This and similar monoclonal antibody medicines have been imported and used in India successfully ( around Rs 60,000 per dose).Cipla has imported from Roche,but it would have been better and cheaper if it was manufacured here as we have the technology and many "mabs" used in other disorders are already manufactured in India. Unlike active vaccines which are used only for prevention, these "mabs" can be used for treatment.

    DisAgree [4] Agree [9] Reply Report Abuse

  • Ajay Rebello, Kallianpur

    Thu, Jun 17 2021

    Centre had removed monoclonal treatment some time back from its sop for covid treatment. God knows why.

    DisAgree Agree [19] Reply Report Abuse


Leave a Comment

Title: Abu Dhabi becomes first city to get revolutionary anti-viral medicine for Covid



You have 2000 characters left.

Disclaimer:

Please write your correct name and email address. Kindly do not post any personal, abusive, defamatory, infringing, obscene, indecent, discriminatory or unlawful or similar comments. Daijiworld.com will not be responsible for any defamatory message posted under this article.

Please note that sending false messages to insult, defame, intimidate, mislead or deceive people or to intentionally cause public disorder is punishable under law. It is obligatory on Daijiworld to provide the IP address and other details of senders of such comments, to the authority concerned upon request.

Hence, sending offensive comments using daijiworld will be purely at your own risk, and in no way will Daijiworld.com be held responsible.